|
|
Volumn 300, Issue 5620, 2003, Pages 714-715
|
|
Infectious diseases: Battling SARS on the frontlines
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
RIBAVIRIN;
STEROID;
CHINA;
CLINICAL FEATURE;
CORONAVIRUS;
DISEASE SEVERITY;
DRUG EFFICACY;
EPIDEMIC;
GEOGRAPHIC DISTRIBUTION;
GOVERNMENT;
HEALTH CARE PERSONNEL;
HIGH RISK POPULATION;
HONG KONG;
HOSPITAL PERSONNEL;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
INFECTION CONTROL;
INFECTION PREVENTION;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MORBIDITY;
NOTE;
PRIORITY JOURNAL;
PROGNOSIS;
PUBLIC HEALTH;
RESPIRATORY TRACT DISEASE;
SEVERE ACUTE RESPIRATORY SYNDROME;
THORAX RADIOGRAPHY;
VIRAL CONTAMINATION;
VIRUS IDENTIFICATION;
VIRUS ISOLATION;
VIRUS PATHOGENESIS;
VIRUS PNEUMONIA;
VIRUS TRANSMISSION;
ANTI-INFLAMMATORY AGENTS;
ANTIVIRAL AGENTS;
CHLAMYDIA INFECTIONS;
COMMUNICABLE DISEASES, EMERGING;
DISEASE OUTBREAKS;
DRUG THERAPY, COMBINATION;
HONG KONG;
HUMANS;
RIBAVIRIN;
SARS VIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
STEROIDS;
CORONAVIRUS;
|
|
EID: 0038671756
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.300.5620.714 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|